Product Name

  • Name

    N-Acetyl-L-aspartic acid

  • EINECS 213-643-9
  • CAS No. 997-55-7
  • Article Data12
  • CAS DataBase
  • Density 1.422 g/cm3
  • Solubility
  • Melting Point 137-140 °C(lit.)
  • Formula C6H9NO5
  • Boiling Point 425.3 °C at 760 mmHg
  • Molecular Weight 175.141
  • Flash Point 211 °C
  • Transport Information
  • Appearance White powder
  • Safety 22-24/25
  • Risk Codes
  • Molecular Structure Molecular Structure of 997-55-7 (N-Acetyl-L-aspartic acid)
  • Hazard Symbols
  • Synonyms Asparticacid, N-acetyl-, L- (8CI);Acetyl-L-aspartic acid;Acetylaspartic acid;L-N-Acetylaspartic acid;N-Acetyl-S-aspartic acid;N-Acetylaspartic acid;
  • PSA 103.70000
  • LogP -0.55870

Synthetic route

L-Aspartic acid
56-84-8

L-Aspartic acid

acetic anhydride
108-24-7

acetic anhydride

N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

Conditions
ConditionsYield
In water for 0.0666667h; Irradiation;99%
(S)-N-acetyl-L-aspartic anhydride
41148-79-2

(S)-N-acetyl-L-aspartic anhydride

N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

Conditions
ConditionsYield
With water
L-Aspartic acid bis(trimethylsilyl) ester
5269-42-1

L-Aspartic acid bis(trimethylsilyl) ester

acetyl chloride
75-36-5

acetyl chloride

N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

Conditions
ConditionsYield
Stage #1: L-Aspartic acid bis(trimethylsilyl) ester; acetyl chloride With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate In dichloromethane at 20℃;
Stage #2: With methanol In dichloromethane at 20℃;
(S)-N-Acetylaminobutyric acid
19146-51-1

(S)-N-Acetylaminobutyric acid

N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

Conditions
ConditionsYield
With hydrogen peroxide; trifluoroacetic acid In water-d2 Kinetics; Photolysis;
N-acetyl-L-aspartyl-L-glutamate
3106-85-2

N-acetyl-L-aspartyl-L-glutamate

A

L-glutamic acid
56-86-0

L-glutamic acid

B

N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

Conditions
ConditionsYield
With glutamate carboxypeptidase II; TACN*Zn(II) complex; 2-hydroxypropyl-p-nitrophenyl phosphate at 40℃; pH=7; Kinetics; aq. buffer; Enzymatic reaction;
L-Aspartic acid
56-84-8

L-Aspartic acid

2-acetyloxy-5-nitrobenzoic acid
17336-14-0

2-acetyloxy-5-nitrobenzoic acid

N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

Conditions
ConditionsYield
In water at 25℃; Kinetics; Concentration;
L-Aspartic acid
56-84-8

L-Aspartic acid

2-acetoxy-5-chloro-benzoic acid
1734-62-9

2-acetoxy-5-chloro-benzoic acid

N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

Conditions
ConditionsYield
In water at 25℃; Kinetics; Concentration;
L-Aspartic acid
56-84-8

L-Aspartic acid

aspirin
50-78-2

aspirin

N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

Conditions
ConditionsYield
In water at 25℃; Kinetics; Concentration;
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

(S)-N-acetyl-L-aspartic anhydride
41148-79-2

(S)-N-acetyl-L-aspartic anhydride

Conditions
ConditionsYield
With acetic anhydride at 20 - 80℃; for 5h;88%
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

3-amino-7-methyl-3,4-dihydro-1,8-naphthyridin-2(1H)-one dihydrochloride

3-amino-7-methyl-3,4-dihydro-1,8-naphthyridin-2(1H)-one dihydrochloride

N-acetyl-L-aspartic acid (3S)-3-amino-7-methyl-3,4-dihydro-1,8-naphthyridin-2(1H)-one salt
1357057-62-5

N-acetyl-L-aspartic acid (3S)-3-amino-7-methyl-3,4-dihydro-1,8-naphthyridin-2(1H)-one salt

Conditions
ConditionsYield
Stage #1: 3-amino-7-methyl-3,4-dihydro-1,8-naphthyridin-2(1H)-one dihydrochloride With sodium hydroxide In dichloromethane at 20℃; for 0.5h;
Stage #2: N-Acetyl-L-aspartic acid In ethanol at 60℃; for 1h;
83%
formaldehyd
50-00-0

formaldehyd

N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

(S)-3-acetyl-5-oxo-4-oxazolidineacetic acid
1316250-66-4

(S)-3-acetyl-5-oxo-4-oxazolidineacetic acid

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene at 80℃; for 0.25h; Microwave irradiation;75%
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

daunomycin hydrochloride
23541-50-6

daunomycin hydrochloride

3'-N-[(N-acetyl)-β-aspartyl]-daunomycin

3'-N-[(N-acetyl)-β-aspartyl]-daunomycin

Conditions
ConditionsYield
With 4-pyrrolidin-1-ylpyridine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 4h;74%
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

glycerol
56-81-5

glycerol

A

rac-1-O-(Nα-acetyl-L-aspartyl-1-yl)glycerol
388587-59-5

rac-1-O-(Nα-acetyl-L-aspartyl-1-yl)glycerol

B

rac-2-O-(Nα-Ac-L-aspart-1-yl)glycerol

rac-2-O-(Nα-Ac-L-aspart-1-yl)glycerol

Conditions
ConditionsYield
With Novozym 435 In various solvent(s) at 50℃; for 24h;A 73%
B n/a
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

doxorubicin hydrochloride
25316-40-9

doxorubicin hydrochloride

3'-N-[(N-acetyl)-β-aspartyl]-doxorubicin

3'-N-[(N-acetyl)-β-aspartyl]-doxorubicin

Conditions
ConditionsYield
With 4-pyrrolidin-1-ylpyridine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 5h;71%
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

doxorubicin hydrochloride
25316-40-9

doxorubicin hydrochloride

3'-N,14-bis[(N-acetyl)-β-aspartyl]-doxorubicin

3'-N,14-bis[(N-acetyl)-β-aspartyl]-doxorubicin

Conditions
ConditionsYield
With 4-pyrrolidin-1-ylpyridine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 10h;67%
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

14-bromodaunorubicin hydrochloride
29742-67-4

14-bromodaunorubicin hydrochloride

daunomycin-14-(N-acetyl)-β-aspartate hydrochloride

daunomycin-14-(N-acetyl)-β-aspartate hydrochloride

Conditions
ConditionsYield
With triethylamine In acetone at 20℃; for 8h;61%
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

zopiclon
43200-80-2

zopiclon

A

(R)-zopiclone N-acetyl-L-aspartate
1107971-11-8

(R)-zopiclone N-acetyl-L-aspartate

B

(S)-zopiclone N-acetyl-L-aspartate
1107971-15-2

(S)-zopiclone N-acetyl-L-aspartate

Conditions
ConditionsYield
In methanol; toluene at 20℃; for 1.21667h; Product distribution / selectivity; Heating / reflux;A 46%
B 43%
In methanol; toluene at 20℃; for 1.21667h; Product distribution / selectivity; Heating / reflux;A 46%
B 43%
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxy-3,4-dihydroquinazoline-4-one
1044870-39-4

2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxy-3,4-dihydroquinazoline-4-one

4-(2-[4-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2,6-dimethylphenoxy]butyl)-4-oxo-2-acetaminobutyric acid

4-(2-[4-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-2,6-dimethylphenoxy]butyl)-4-oxo-2-acetaminobutyric acid

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In acetone at 0 - 20℃; for 24h;45%
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

zopiclon
43200-80-2

zopiclon

(R)-zopiclone N-acetyl-L-aspartate
1107971-11-8

(R)-zopiclone N-acetyl-L-aspartate

Conditions
ConditionsYield
In methanol; xylene at 20℃; for 1.16667h; Product distribution / selectivity; Heating / reflux;41%
In methanol; xylene at 20℃; for 1.16667h; Product distribution / selectivity; Heating / reflux;41%
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

C16H22F3NO4

C16H22F3NO4

C38H49F6N3O11

C38H49F6N3O11

Conditions
ConditionsYield
Stage #1: N-Acetyl-L-aspartic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 0.5h;
Stage #2: C16H22F3NO4 In dichloromethane at 20℃; for 2h;
38%
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

tetraethyl 3-aminopropylidene-1,1-bisphosphonate
141473-49-6

tetraethyl 3-aminopropylidene-1,1-bisphosphonate

[3-{2-acetylamino-3-[3,3-bis-(diethoxy-phosphoryl)-propylcarbamoyl]-propionylamino}-1-(diethoxy-phosphoryl)-propyl]-phosphonic acid diethyl ester

[3-{2-acetylamino-3-[3,3-bis-(diethoxy-phosphoryl)-propylcarbamoyl]-propionylamino}-1-(diethoxy-phosphoryl)-propyl]-phosphonic acid diethyl ester

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In dichloromethane at 20℃;
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

{3-[2-acetylamino-3-(3,3-bis-phosphono-propylcarbamoyl)-propionylamino]-1-phosphono-propyl}-phosphonic acid

{3-[2-acetylamino-3-(3,3-bis-phosphono-propylcarbamoyl)-propionylamino]-1-phosphono-propyl}-phosphonic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: BOP; triethylamine / CH2Cl2 / 20 °C
2: TMSBr / CH2Cl2 / 20 °C
View Scheme
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

cis-(+/-)-2-phenylpiperidin-3-ylamine

cis-(+/-)-2-phenylpiperidin-3-ylamine

C23H30N4O8

C23H30N4O8

Conditions
ConditionsYield
In methanol at 20 - 50℃; for 2.16667h;n/a
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

bis(tri-n-butyltin)oxide
56-35-9

bis(tri-n-butyltin)oxide

N-acetyl-L-OCOCH2CHNHCOO-bis(tri-n-butyltin)

N-acetyl-L-OCOCH2CHNHCOO-bis(tri-n-butyltin)

Conditions
ConditionsYield
In toluene byproducts: H2O; azeotropic dehydration with toluene; recrystn. (benzene) or sublimation;
copper(II) acetate hydrate

copper(II) acetate hydrate

N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

(Cu(OOCCH(NHCOCH3)CH2COO)(H2O))2*2H2O

(Cu(OOCCH(NHCOCH3)CH2COO)(H2O))2*2H2O

Conditions
ConditionsYield
In water reaction of Cu(ac)2 with N-acetyl-L-aspartic acid in water; concn. of the soln. at 50°C, elem. anal.;
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

L-Aspartic acid
56-84-8

L-Aspartic acid

Conditions
ConditionsYield
With recombinant Streptomyces mobaraensis aminoacylase; water at 37℃; pH=7.5; aq. buffer; Enzymatic reaction;
With E. coli BL21 Star (DE3) S30 extract In aq. buffer at 37℃; for 6h; pH=7.5;
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

C12H17NO7

C12H17NO7

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: toluene-4-sulfonic acid / toluene / 0.25 h / 80 °C / Microwave irradiation
2: 4-methyl-morpholine / tetrahydrofuran / -15 °C / Inert atmosphere
View Scheme
N-Acetyl-L-aspartic acid
997-55-7

N-Acetyl-L-aspartic acid

C7H11NO4

C7H11NO4

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: toluene-4-sulfonic acid / toluene / 0.25 h / 80 °C / Microwave irradiation
2: 4-methyl-morpholine / tetrahydrofuran / -15 °C / Inert atmosphere
3: sodium tetrahydroborate / tetrahydrofuran
View Scheme

N-Acetyl-L-aspartic acid Chemical Properties

Molecular Structure:

Molecular Formula: C6H9NO5
Molecular Weight: 175.1394
IUPAC Name: (2S)-2-Acetamidobutanedioate
Synonyms of N-Acetyl-L-aspartic acid (CAS NO.997-55-7): N-Acetylaspartate ; 4-04-00-03015 (Beilstein Handbook Reference) ; Acetyl-L-aspartic acid ; Acetylaspartic acid ; BRN 1726198 ; EINECS 213-643-9 ; L-N-Acetylaspartic acid ; N-Acetylaspartic acid ; NSC 128610 ; Aspartic acid, N-acetyl-, L- (8CI) ; L-Aspartic acid, N-acetyl-
CAS NO: 997-55-7
Classification Code: Drug / Therapeutic Agent
Melting point: 137-140 °C
Index of Refraction: 1.505
Molar Refractivity: 36.55 cm3
Molar Volume: 123.1 cm3
Surface Tension: 61.5 dyne/cm
Density: 1.422 g/cm3
Flash Point: 211 °C
Enthalpy of Vaporization: 74.57 kJ/mol
Boiling Point: 425.3 °C at 760 mmHg
Vapour Pressure of N-Acetyl-L-aspartic acid (CAS NO.997-55-7): 2E-08 mmHg at 25°C

N-Acetyl-L-aspartic acid Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 2660mg/kg (2660mg/kg)   Pharmaceutical Chemistry Journal Vol. 25, Pg. 569, 1991.

N-Acetyl-L-aspartic acid Safety Profile

Safety Statements of N-Acetyl-L-aspartic acid (CAS NO.997-55-7): 22-24/25 
S22: Do not breathe dust. 
S24/25: Avoid contact with skin and eyes.
WGK Germany: 1
RTECS: CI9098600

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View